{
  "report_rows": [
    {
      "kpi": "Q2 2026 revenue",
      "prediction": "BEAT",
      "answer": "pred ~$3.04B vs. cons $3.00B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 2026 adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$3.96 vs. cons $3.85",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 2026 organic revenue growth",
      "prediction": "BEAT",
      "answer": "pred ~1.5% vs. cons 1.0%",
      "confidence": "LOW"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Q3 2026 revenue growth",
      "prediction": "BETTER",
      "answer": "guide ~10.5% vs. cons 10.2% (Q3 2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q3 2026 adjusted EPS",
      "prediction": "BETTER",
      "answer": "guide ~$4.55 vs. cons $4.49 (Q3 2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 revenue",
      "prediction": "BETTER",
      "answer": "guide ~$12.90B vs. cons $12.84B (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 adjusted EPS",
      "prediction": "BETTER",
      "answer": "guide ~$17.14 vs. cons $17.02 (FY2026)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 3.1,
  "day1_confidence": "LOW",
  "day5_residual_pct": 1.8,
  "day5_path": "FADE",
  "day5_rationale": "The projected FY2026 EPS guide rises ~$0.12 versus consensus while the Q2 beat is ~$0.11, leaving only ~$0.01 of implied second-half upside; similarly, the ~$60M FY revenue uplift versus consensus exceeds the ~$40M Q2 beat by only ~$20M, so limited out-period revisions should partially fade the initial reaction.",
  "day5_confidence": "LOW"
}